Chemical synthesis today constitutes the primary production method for vitamin C, for both pharmaceutical and cosmetic applications. It is primarily based on the Reichstein process, developed in the 1930s and still employed, in optimised forms, on an industrial scale. This process enables the conversion of D-glucose, most commonly derived from maize starch, into L-ascorbic acid, the biologically active form of vitamin C.
Synthetic vitamin C is strictly identical, both chemically and biologically, to the vitamin C naturally present in plants.
Several consecutive steps are required, combining organic chemistry and biotechnology, in order to obtain the correct stereoisomer. Initially, glucose is hydrogenated into D-sorbitol using a Raney nickel catalyst. This sorbitol is then oxidised by microbial fermentation to yield L-sorbose, a key step that ensures the correct stereochemical configuration of the molecule. The hydroxyl groups of L-sorbose are then protected by forming acetals in the presence of acetone and sulphuric acid at low temperature, before a chemical oxidation classically carried out with potassium permanganate under alkaline conditions.
The final step involves the closure of the lactone ring, allowing the formation of ascorbic acid. It can be achieved either by heating in an aqueous medium or by esterification followed by treatment with sodium methoxide, before a final acidification. More modern variants of the process also include a direct oxidation in the presence of oxygen and a platinum catalyst, aimed at improving yields.
At Typology, we use stable derivatives of vitamin C obtained from D-glucose via the Reichstein–Grüssner process, combining chemical steps and a microbiological step.